Atreca Inc Valuation

BCELDelisted Stock  USD 1.04  0.02  1.89%   
Today, the firm appears to be overvalued. Atreca Inc shows a prevailing Real Value of $0.89 per share. The current price of the firm is $1.04. Our model approximates the value of Atreca Inc from analyzing the firm fundamentals such as Shares Owned By Insiders of 2.73 %, return on equity of -1.83, and Current Valuation of (17.08 M) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
1.04
Please note that Atreca's price fluctuation is very steady at this time. Calculation of the real value of Atreca Inc is based on 3 months time horizon. Increasing Atreca's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Atreca pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Atreca Inc. Since Atreca is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Atreca Pink Sheet. However, Atreca's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.04 Real  0.89 Hype  1.04 Naive  1.14
The intrinsic value of Atreca's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Atreca's stock price.
0.89
Real Value
1.14
Upside
Estimating the potential upside or downside of Atreca Inc helps investors to forecast how Atreca pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Atreca more accurately as focusing exclusively on Atreca's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.941.031.12
Details
Hype
Prediction
LowEstimatedHigh
1.041.041.04
Details
Naive
Forecast
LowNext ValueHigh
1.141.141.14
Details

Atreca Total Value Analysis

Atreca Inc is currently forecasted to have valuation of (17.08 M) with market capitalization of 3.02 M, debt of 63.88 M, and cash on hands of 101.73 M. The negative valuation of Atreca may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Atreca fundamentals.
  Takeover PriceMarket CapDebt ObligationsCash
(17.08 M)
3.02 M
63.88 M
101.73 M

Atreca Asset Utilization

One of the ways to look at asset utilization of Atreca is to check how much profit was generated for every dollar of assets it reports. Atreca Inc shows a negative utilization of assets of -0.51 percent, losing $0.00512 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Atreca Inc shows how discouraging it operates for each dollar spent on its assets.

Atreca Ownership Allocation

Atreca holds a total of 38.41 Million outstanding shares. Almost 72.73 percent of Atreca outstanding shares are held by general public with 2.73 (percent) owned by insiders and only 24.54 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Atreca Profitability Analysis

Net Loss for the year was (97.76 M) with profit before overhead, payroll, taxes, and interest of 0.

About Atreca Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Atreca Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Atreca Inc based exclusively on its fundamental and basic technical indicators. By analyzing Atreca's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Atreca's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Atreca. We calculate exposure to Atreca's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Atreca's related companies.
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California. Atreca Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.

8 Steps to conduct Atreca's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Atreca's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Atreca's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Atreca's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Atreca's revenue streams: Identify Atreca's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Atreca's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Atreca's growth potential: Evaluate Atreca's management, business model, and growth potential.
  • Determine Atreca's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Atreca's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Atreca Growth Indicators

Investing in growth stocks can be very risky. If the company such as Atreca does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding38.6 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Consideration for investing in Atreca Pink Sheet

If you are still planning to invest in Atreca Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Atreca's history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum